# Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.

> **NCT03334682** · PHASE3 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 158 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** spironolactone
- **DRUG:** Doxycycline

## Key facts

- **NCT ID:** NCT03334682
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2023-02-03
- **Final completion:** 2023-07-04
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2023-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03334682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03334682, "Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03334682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*